The Guardian Australia ·general ·46 minutes ago

Medical experts rename polycystic ovarian syndrome to improve diagnosis and treatment

Polycystic ovarian syndrome has been officially renamed polyendocrine metabolic ovarian syndrome, or PMOS, in hopes of improving care for affected women. The condition impacts 10-13% of women of reproductive age, though over two-thirds remain undiagnosed. Health experts say the old name was misleading and contributed to poor treatment outcomes.

Summary by Glance · The Guardian Australia

Newer
Next